Lantheus Holdings, Inc. (LNTH) stock
LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3014% above fair value
$102.00+0.20 (+0.20%)
Close on Nov 18, 2026Market cap $6.66BP/E 24.7Yield –
Lantheus free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Lantheus's free cash flow for the twelve months ending Dec 31, 2023 was $259.92M, up 1093.3% year over year. For fiscal 2023 it was $259.92M, up 1093.3% from the year before. The highest annual figure on record is $259.92M in fiscal 2023.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $259.92M | +1093.3% |
| FY2022 | Dec 31, 2022 | $21.78M | -59.6% |
| FY2021 | Dec 31, 2021 | $53.92M | +228.8% |
| FY2020 | Dec 31, 2020 | $16.40M | -71.9% |
| FY2019 | Dec 31, 2019 | $58.32M | +42.0% |
| FY2018 | Dec 31, 2018 | $41.06M | +10.3% |
| FY2017 | Dec 31, 2017 | $37.23M | -11.9% |
| FY2016 | Dec 31, 2016 | $42.24M | +390.6% |
| FY2015 | Dec 31, 2015 | $8.61M | +149.4% |
| FY2014 | Dec 31, 2014 | $3.45M | – |
| FY2013 | Dec 31, 2013 | -$20.58M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $112.29M | – |
| Q3 FY2023 | Sep 30, 2023 | $116.74M | +24.8% |
| Q2 FY2023 | Jun 30, 2023 | -$42.27M | -158.2% |
| Q1 FY2023 | Mar 31, 2023 | $73.16M | +612.7% |
| Q4 FY2022 | Dec 31, 2022 | -$154.65M | -819.8% |
| Q3 FY2022 | Sep 30, 2022 | $93.57M | +4773.3% |
| Q2 FY2022 | Jun 30, 2022 | $72.60M | +212.7% |
| Q1 FY2022 | Mar 31, 2022 | $10.26M | +40.6% |
| Q4 FY2021 | Dec 31, 2021 | $21.49M | +132.1% |
| Q3 FY2021 | Sep 30, 2021 | $1.92M | -60.3% |
| Q2 FY2021 | Jun 30, 2021 | $23.21M | – |
| Q1 FY2021 | Mar 31, 2021 | $7.30M | +8.8% |
| Q4 FY2020 | Dec 31, 2020 | $9.26M | -47.6% |
| Q3 FY2020 | Sep 30, 2020 | $4.84M | -79.1% |
| Q2 FY2020 | Jun 30, 2020 | -$4.41M | -125.0% |
| Q1 FY2020 | Mar 31, 2020 | $6.71M | – |
| Q4 FY2019 | Dec 31, 2019 | $17.68M | +77.9% |
| Q3 FY2019 | Sep 30, 2019 | $23.11M | +19.9% |
| Q2 FY2019 | Jun 30, 2019 | $17.62M | +20.3% |
| Q1 FY2019 | Mar 31, 2019 | -$82.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $9.94M | +39.4% |
| Q3 FY2018 | Sep 30, 2018 | $19.27M | +56.5% |
| Q2 FY2018 | Jun 30, 2018 | $14.65M | -14.7% |
| Q1 FY2018 | Mar 31, 2018 | -$2.80M | -548.2% |
| Q4 FY2017 | Dec 31, 2017 | $7.13M | -31.2% |
| Q3 FY2017 | Sep 30, 2017 | $12.31M | -4.2% |
| Q2 FY2017 | Jun 30, 2017 | $17.17M | – |
| Q1 FY2017 | Mar 31, 2017 | $625.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $10.36M | – |
| Q3 FY2016 | Sep 30, 2016 | $12.86M | – |
See a number that looks wrong?